474 related articles for article (PubMed ID: 22833210)
1. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
[TBL] [Abstract][Full Text] [Related]
2. Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.
Yu Y; Lin Y; Takasaki Y; Wang C; Kimura H; Xing J; Ishizuka K; Toyama M; Kushima I; Mori D; Arioka Y; Uno Y; Shiino T; Nakamura Y; Okada T; Morikawa M; Ikeda M; Iwata N; Okahisa Y; Takaki M; Sakamoto S; Someya T; Egawa J; Usami M; Kodaira M; Yoshimi A; Oya-Ito T; Aleksic B; Ohno K; Ozaki N
Transl Psychiatry; 2018 Jan; 8(1):12. PubMed ID: 29317596
[TBL] [Abstract][Full Text] [Related]
3. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
[TBL] [Abstract][Full Text] [Related]
4. De novo GRIN2A variants associated with epilepsy and autism and literature review.
Mangano GD; Riva A; Fontana A; Salpietro V; Mangano GR; Nobile G; Orsini A; Iacomino M; Battini R; Astrea G; Striano P; Nardello R
Epilepsy Behav; 2022 Apr; 129():108604. PubMed ID: 35217385
[TBL] [Abstract][Full Text] [Related]
5. Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population.
Takasaki Y; Koide T; Wang C; Kimura H; Xing J; Kushima I; Ishizuka K; Mori D; Sekiguchi M; Ikeda M; Aizawa M; Tsurumaru N; Iwayama Y; Yoshimi A; Arioka Y; Yoshida M; Noma H; Oya-Ito T; Nakamura Y; Kunimoto S; Aleksic B; Uno Y; Okada T; Ujike H; Egawa J; Kuwabara H; Someya T; Yoshikawa T; Iwata N; Ozaki N
Sci Rep; 2016 Sep; 6():33311. PubMed ID: 27616045
[TBL] [Abstract][Full Text] [Related]
6. Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk.
Demontis D; Nyegaard M; Buttenschøn HN; Hedemand A; Pedersen CB; Grove J; Flint TJ; Nordentoft M; Werge T; Hougaard DM; Sørensen KM; Yolken RH; Mors O; Børglum AD; Mortensen PB
Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):913-22. PubMed ID: 21919190
[TBL] [Abstract][Full Text] [Related]
7. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
[TBL] [Abstract][Full Text] [Related]
8. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
[TBL] [Abstract][Full Text] [Related]
9. Paradigmatic De Novo
Santos-Gómez A; Miguez-Cabello F; Juliá-Palacios N; García-Navas D; Soto-Insuga V; García-Peñas JJ; Fuentes P; Ibáñez-Micó S; Cuesta L; Cancho R; Andreo-Lillo P; Gutiérrez-Aguilar G; Alonso-Luengo O; Málaga I; Hedrera-Fernández A; García-Cazorla À; Soto D; Olivella M; Altafaj X
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884460
[TBL] [Abstract][Full Text] [Related]
10. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
Endele S; Rosenberger G; Geider K; Popp B; Tamer C; Stefanova I; Milh M; Kortüm F; Fritsch A; Pientka FK; Hellenbroich Y; Kalscheuer VM; Kohlhase J; Moog U; Rappold G; Rauch A; Ropers HH; von Spiczak S; Tönnies H; Villeneuve N; Villard L; Zabel B; Zenker M; Laube B; Reis A; Wieczorek D; Van Maldergem L; Kutsche K
Nat Genet; 2010 Nov; 42(11):1021-6. PubMed ID: 20890276
[TBL] [Abstract][Full Text] [Related]
11. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
12. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395
[TBL] [Abstract][Full Text] [Related]
13. In-silico investigation of coding variants potentially affecting the functioning of the glutamatergic N-methyl-D-aspartate receptor in schizophrenia.
Tsavou A; Curtis D
Psychiatr Genet; 2019 Apr; 29(2):44-50. PubMed ID: 30664045
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of
Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
F1000Res; 2019; 8():. PubMed ID: 31807283
[TBL] [Abstract][Full Text] [Related]
15. Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders.
Shepard N; Baez-Nieto D; Iqbal S; Kurganov E; Budnik N; Campbell AJ; Pan JQ; Sheng M; Farsi Z
Sci Rep; 2024 Feb; 14(1):2798. PubMed ID: 38307912
[TBL] [Abstract][Full Text] [Related]
16. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
Piton A; Gauthier J; Hamdan FF; Lafrenière RG; Yang Y; Henrion E; Laurent S; Noreau A; Thibodeau P; Karemera L; Spiegelman D; Kuku F; Duguay J; Destroismaisons L; Jolivet P; Côté M; Lachapelle K; Diallo O; Raymond A; Marineau C; Champagne N; Xiong L; Gaspar C; Rivière JB; Tarabeux J; Cossette P; Krebs MO; Rapoport JL; Addington A; Delisi LE; Mottron L; Joober R; Fombonne E; Drapeau P; Rouleau GA
Mol Psychiatry; 2011 Aug; 16(8):867-80. PubMed ID: 20479760
[TBL] [Abstract][Full Text] [Related]
17. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders.
Kenny EM; Cormican P; Furlong S; Heron E; Kenny G; Fahey C; Kelleher E; Ennis S; Tropea D; Anney R; Corvin AP; Donohoe G; Gallagher L; Gill M; Morris DW
Mol Psychiatry; 2014 Aug; 19(8):872-9. PubMed ID: 24126926
[TBL] [Abstract][Full Text] [Related]
18. Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders.
Yoo HJ; Cho IH; Park M; Yang SY; Kim SA
Neurosci Lett; 2012 Mar; 512(2):89-93. PubMed ID: 22326929
[TBL] [Abstract][Full Text] [Related]
19. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.
Korinek M; Serra MC; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A
Physiol Res; 2024 May; ():. PubMed ID: 38836461
[TBL] [Abstract][Full Text] [Related]
20. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
